HSCI does not enroll any volunteers in clinical trials.
Currently, the only stem cell-based treatment that is routinely reviewed and approved by the U.S. Food and Drug Administration (FDA) is hematopoietic (or blood) stem cell transplantation. It is used to treat patients with cancers and disorders that affect the blood and immune system. Stem cell-based therapies for all other conditions are still experimental.
The website ClinicalTrials.gov has the most up-to-date information about clinical trials that are testing whether stem cell-based therapies are safe and effective in humans. If you have questions about specific clinical trials, the only people who can answer them properly are those who are listed as the primary contact for each study listed on ClinicalTrials.gov.